Biological medication for rheuma

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L04AA24|L04AC03|L04AB04|L04AB01|L04AB06|L04AB02|L04AB05|L04AA26|L01XC02|L04AC10|L04AC07|L04AC05

1 out of 7 registries used, show all original rules.

5294

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

5294

diagram downward connector

Include endpoints None

5294

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

5117

diagram downward connector
RX_RHEUMA_BIOLOGICAL

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 5117 3157 1960
Unadjusted prevalence (%) 1.24 1.37 1.08
Mean age at first event (years) 46.91 46.66 47.32

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 2.99 [1.31, 6.84] 9.3e-3 92
15 years 0.02 2.02 [0.87, 4.67] 1.0e-1 62
5 years 0.00 1.73 [0.87, 3.48] 1.2e-1 19
1 year 0.00 5.16 [2.40, 11.10] 2.7e-5 11

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma
GWS hits: 4

Survival analyses between endpoints

Plot

before Biological medication for rheuma
after Biological medication for rheuma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medication for rheuma

Endpoint not on priority list, no data to show.